BDNF / NGF induction
What it is
Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are the primary neurotrophins governing neuronal survival, synaptic plasticity, and structural neuroplasticity. Induction means increasing endogenous synthesis, not direct administration. Different compounds induce them via different upstream pathways — TrkA/TrkB receptor activation, astrocytic PI3K/Akt signaling, or transcriptional upregulation.
Why it matters for Vitals
Neurotrophin support is the structural substrate for cognitive improvement, memory consolidation, and recovery from neural insults. In Vitals logic:
- Cognitive benchmarks: BDNF/NGF-mediated improvements in processing speed, executive function, and memory — trackable via digital cognitive tools
- Sleep quality: BDNF modulates hippocampal sharp-wave ripples and cortical plasticity during sleep
- Recovery from insults: alcohol, cocaine, and other neurotoxic substances suppress BDNF — compounds that induce BDNF support restoration
- Motor learning: NGF supports cholinergic basal forebrain; BDNF supports motor cortex plasticity
How different compounds induce it
| Compound | Primary pathway | Mechanism |
|---|---|---|
| Lion’s Mane (erinacines) | TrkA/TrkB receptor activation | Erinacines stimulate glial NGF/BDNF synthesis → paracrine TrkA/TrkB activation |
| Dihexa | HGF/c-Met → PI3K/Akt | Allosteric HGF facilitator → c-Met → PI3K/Akt → synaptogenesis (BDNF-axis adjacent) |
| 9-MBC | Astrocytic PI3K/Akt | Enters astrocytes via OCT → PI3K/Akt → BDNF/GDNF/Artemin release |
| Noopept | Transcriptional upregulation | Chronic administration → sustained BDNF/NGF/NT-3 in cortex + hippocampus |
| Semax | ACTH analog / MC4R | BDNF upregulation in deficit states only (adaptive) |
| Bacopa monnieri | PI3K/Akt → pCREB → BDNF | PI3K/AKT cascade → phosphorylates CREB → BDNF mRNA synthesis; 3T DTI/NODDI MRI confirmed dendritic arborization |
| Ashwagandha | PI3K/Akt → pCREB → BDNF | Withaferin A → PI3K/AKT → pCREB → BDNF promoter activation; rescues scopolamine amnesia |
Key distinctions for retrieval
TrkA vs TrkB: NGF activates TrkA; BDNF activates TrkB. Some compounds (Lion’s Mane erinacines) induce both. The distinction matters for cognitive vs motor applications.
Astrocytic vs neuronal: 9-Me-BC and Lion’s Mane work partly via astrocytic signaling — the neurotrophins are released from astrocytes, not neurons directly. This is more physiological and less prone to receptor saturation.
Adaptive vs constitutive: Semax and Noopept are adaptive modulators — they upregulate BDNF/NGF only when baseline is deficient. Lion’s Mane and 9-MBC appear to work more constitutively (with cycling to prevent receptor downregulation in LM’s case).
Main evidence
- Lion’s Mane: RCT-validated cognitive speed improvement; 24-month dementia trials
- Dihexa: ~3× dendritic spine increase in rat hippocampal neurons (independent Chinese validation)
- 9-MBC: MPP⁺ full DA neuron regeneration in vivo; transdifferentiation confirmed
- Noopept: sustained BDNF in cortex + hippocampus, 28-day chronic, no tolerance
Confidence level
- Lion’s Mane: high (multiple human RCTs)
- Dihexa: moderate (preclinical; prodrug failed in humans but mechanism confirmed)
- 9-MBC: low-moderate (rigorous preclinical, zero human data)
- Noopept/Semax: moderate (Russian clinical use, adaptive mechanism well-characterized)
- Bacopa monnieri: high (2024 Creyos RCT confirmed BDNF Day 84; 3T DTI/NODDI MRI structural confirmation)
- Ashwagandha: moderate (BDNF elevation in preclinical/scopolamine models; human BDNF data less direct than Bacopa)
Related notes
- Lion’s Mane — anchor substance for TrkA/TrkB erinacine pathway
- Dihexa — anchor for HGF/c-Met synaptogenesis (BDNF-axis adjacent)
- 9-MBC — anchor for astrocytic PI3K/Akt BDNF induction
- Noopept Semax Selank — adaptive BDNF modulators
- NMN NAD+ — SIRT3 supports mitochondrial function for neurotrophin-active neurons